FYI - For Your Innovation cover image

$7 Trillion For Chips and Drug Pricing | The Brainstorm EP 35

FYI - For Your Innovation

00:00

Viability of Mark Cuban's Generics Company

This chapter dives into the analysis of Mark Cuban's company, Cost Plus Drugs, which specializes in generics. It explores the profitability of this business model, highlighting the significance of manufacturing capabilities, drug production costs, and the future landscape of the industry.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app